Grant: Master's Award: Canada Graduate Scholarships
University of British Columbia
$17,500.00
Engineering Expression of His-tag Labelled Proteins by Human Platelets
EF 2020-21
Résumé
Platelets are small, simple cells that play many roles in the body, from clotting to immune response. When they are made, platelets contain all the necessary cell machinery to make proteins. However, only a select few proteins seem to be made in platelets, and much about the necessary modifications and steps of protein production in platelets is unknown. Therefore, we wanted to express foreign proteins in platelets to help determine what protein production capabilities platelets have, and the necessary modifications for production to occur. To achieve this, we will encase the protein synthesis directions (mRNA) in incredibly small lipid systems, called lipid nanoparticles (LNPs). The LNPs will then protect the mRNA until it can be taken up into platelets and be translated into protein. The mRNA will encode for reporter proteins, to allow for easy visualization and detection, and contain modifications based off known proteins that are translated in platelets. Analyses to determine if the proteins have been made will be completed using several different techniques. In the future, modifications of platelet protein production could have many different clinical implications. ""Designer-platelets"" could be produced with enhanced functions, adding a layer of control to the role of platelets within a patient. For example, platelets transfused to treat acute or severe hemorrhage could be made to express additional clotting factors, enhancing their ability to stop bleeding. Additionally, in cancer treatments where platelets are already being transfused, protein expression would help target therapies to tumors, expanding the role of platelets into a new cell therapy.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
449343
Name
Robertson Madelaine K
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Engineering Expression of His-tag Labelled Proteins by Human Platelets
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Cell Therapy; Drug Delivery; Drug Targeting; Hemorrhage; Lipid Nanoparticles; Mrna Modifications; Nucleic Acid Delivery; Platelet Engineering; Platelet Proteome; Platelet Translation
Abstract
Platelets are small, simple cells that play many roles in the body, from clotting to immune response. When they are made, platelets contain all the necessary cell machinery to make proteins. However, only a select few proteins seem to be made in platelets, and much about the necessary modifications and steps of protein production in platelets is unknown. Therefore, we wanted to express foreign proteins in platelets to help determine what protein production capabilities platelets have, and the necessary modifications for production to occur. To achieve this, we will encase the protein synthesis directions (mRNA) in incredibly small lipid systems, called lipid nanoparticles (LNPs). The LNPs will then protect the mRNA until it can be taken up into platelets and be translated into protein. The mRNA will encode for reporter proteins, to allow for easy visualization and detection, and contain modifications based off known proteins that are translated in platelets. Analyses to determine if the proteins have been made will be completed using several different techniques. In the future, modifications of platelet protein production could have many different clinical implications. ""Designer-platelets"" could be produced with enhanced functions, adding a layer of control to the role of platelets within a patient. For example, platelets transfused to treat acute or severe hemorrhage could be made to express additional clotting factors, enhancing their ability to stop bleeding. Additionally, in cancer treatments where platelets are already being transfused, protein expression would help target therapies to tumors, expanding the role of platelets into a new cell therapy.
Competitiondate
202012
Approvedterm2
1 yr 0 mth
Pinamesdelim
Robertson, Madelaine K
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~